In this article, we will take a detailed look at the 11 Growth Stocks That Could Double by 2027.
The focus should be on growth stocks over value stocks, as volatility in the equity markets has subsided significantly. That’s the stance held at Ned Davis Research after the Cboe Volatility Index dropped to 17 from a peak of 60 in the aftermath of President Donald Trump sending a shockwave with trade tariffs in April.
Stability has returned to the markets, as depicted by the S&P 500 recouping all the losses accrued in April. Investors remained worried that tariffs would tip the economy into recession. Consequently, analysts at Ned Davis insist that growth stocks, which trade on expectations of strong earnings growth, should hold a dominant position in portfolios.
“We are also shifting our style recommendation from neutral to favoring Growth over Value,” Ed Clissold, the Ned Davis chief U.S. strategist, wrote in a note Wednesday. “At the beginning of the year, Mag 7 stocks, which tend to be classified as Growth, were facing slower earnings growth and high valuations. The correction removed Mag 7′s relative overvaluation,” he added. Most “Magnificent Seven” stocks were under pressure at the height of the tariff scare. Since then, most have staged strong rebounds.
Optimism around artificial intelligence has also helped lift growth stocks. Likewise, Wall Street analysts insist investors seeking sustainable long-term returns should look into companies with solid long-term growth potential.
With that in mind, let’s look at the 11 Growth Stocks That Could Double by 2027.
A close-up of an investor pointing to a chart featured on a projector, conveying a message of growth.
Our Methodology
To compile the list of the 11 Growth Stocks That Could Double by 2027, we analyzed high-profile ETF portfolios (Vanguard Growth ETF, iShares Russell 1000 Growth ETF, Schwab U.S. Large-Cap Growth ETF etc.) focusing on growth stocks. We focused on companies across all the key sectors and those that boast significant five-year earnings growth potential. Finally, we ranked stocks popular among elite hedge funds in ascending order based on their five-year earnings growth potential.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
Growth Stocks That Could Double by 2027
11. Alibaba Group Holding Ltd (NYSE:BABA)
EPS Growth this Year: -1.44%
Expected 5-Year EPS Growth: 8.76%
Number of Hedge Fund Holders: 125
Alibaba Group Holding Ltd. (NYSE:BABA) is one of the growth stocks that could double by 2027. On July 11, BofA Securities reiterated a ‘Buy’ rating on the stock but cut its price target to $135 from $145. The adjustment is in response to the Chinese tech giant increasing its investments in food and on-demand delivery services.
Following the investments, Alibaba’s food and on-demand delivery services have experienced significant growth. The orders have increased from 30 million per day to 60 million per day by June, following the launch of Taobao Insta-shopping. The increase has occurred amid a significant rise in traffic on the Taobao App and substantial consumer subsidies.
BofA cut its price target on concerns that losses attributed to the investment have increased to RMB 10 billion. Nevertheless, Alibaba has announced plans to invest RMB 50 billion in food and on-demand delivery, seeking to accelerate growth in this segment.
Alibaba Group Holding Ltd. (NYSE:BABA) is a Chinese multinational company that operates e-commerce platforms, connecting buyers and sellers in various ways. It enables business-to-business (B2B) and business-to-consumer (B2C) transactions and also offers services in digital media, cloud computing, and fintech.
10. Zscaler Inc. (NASDAQ:ZS)
EPS Growth this Year: 0.04%
Expected 5-Year EPS Growth: 11.75%
Number of Hedge Fund Holders: 46
Zscaler Inc. (NASDAQ:ZS) is one of the growth stocks that could double in value by 2027. On July 1, JMP Securities reaffirmed its Market Outperform rating on Zscaler and raised its price target to $355 from $310.
The upgrade reflects confidence in Zscaler’s robust financial performance, including 25.5% revenue growth over the past year and gross margins of 77.5%. The company’s stock has surged 74% year-to-date, far outpacing the broader Russell 3000 index.
The revised outlook follows investor meetings held in Los Angeles with senior Zscaler executives, where JMP analyst Trevor Walsh highlighted the company’s strong positioning in the cybersecurity space. The firm sees continued upside potential driven by Zscaler’s expanding product portfolio and growing enterprise demand.
Zscaler Inc. (NASDAQ:ZS) is a global cloud security provider headquartered in San Jose, California. Its platform offers secure access to external and internal applications, digital experience monitoring, and advanced zero-trust solutions for enterprises. Zscaler serves a wide range of industries, including finance, healthcare, retail, and government, with a focus on scalable, cloud-native cybersecurity infrastructure.
9. AAON, Inc. (NASDAQ:AAON)
EPS Growth this Year: -0.41%
Expected 5-Year EPS Growth: 17.00%
Number of Hedge Fund Holders: 18
AAON, Inc. (NASDAQ:AAON) is one of the growth stocks that could double by 2027. On June 16, Sidoti upgraded AAON from Neutral to Buy, setting a revised price target of $95.00.
The move followed a sharp drop in AAON’s share price after its June 10 investor day, where the company lowered Q2 guidance and introduced three-year targets below market expectations. Despite the selloff, AAON maintains solid financial health, including a strong current ratio and manageable debt.
Sidoti analyst Julio Romero sees the pullback as a buying opportunity, citing AAON’s long-term growth potential and exposure to high-demand sectors like data centers, HVAC, and electrification. With a five-year revenue CAGR of 21% and current growth at 8.24%, the firm believes the stock is well-positioned for recovery and expansion.
AAON, Inc. (NASDAQ:AAON) designs and manufactures HVAC systems across North America, serving industries from retail and education to data centers and pharmaceuticals. Operating through AAON Oklahoma, AAON Coil Products, and BASX, the company offers rooftop units, chillers, cleanroom systems, and geothermal heat pumps.
8. Argan, Inc. (NYSE:AGX)
EPS Growth this Year: 8.80%
Expected 5-Year EPS Growth: 17.00%
Number of Hedge Fund Holders:
Argan, Inc. (NYSE:AGX) is one of the growth stocks that could double by 2027. On July 21, JPMorgan initiated coverage on AGX with a Neutral rating and a $220 price target, citing the company’s strong position in the engineering, procurement, and construction (EPC) space through its Gemma subsidiary.
The firm sees Argan as a key player in the anticipated multi-year buildout of U.S. gas power plants, which is expected to drive the bulk of its growth. Argan’s exposure to solar-plus-storage and industrial construction adds diversification, though JPMorgan notes recent volatility tied to AI data center themes. The bank suggests a more favorable outlook could emerge if the stock experiences a meaningful pullback from current levels.
Argan, Inc. (NYSE:AGX) delivers EPC and technical services for large-scale energy projects across the U.S., Ireland, and the U.K. Its operations span power generation, industrial construction, and telecom infrastructure, serving clients in sectors ranging from utilities and manufacturing to government and technology.
7. Super Micro Computer, Inc. (NASDAQ:SMCI)
EPS Growth this Year: -4.96%
Expected 5-Year EPS Growth: 17.09%
Number of Hedge Fund Holders: 40
Super Micro Computer, Inc. (NASDAQ:SMCI) is one of the growth stocks that could double by 2027. On July 16, 2025, SMCI entered into a $1.79 billion Receivables Purchase Agreement with MUFG Bank, Crédit Agricole, and other financial institutions.
The uncommitted facility allows Super Micro to sell eligible accounts receivable at discounted rates based on Term SOFR plus 1.15%–2.80%, depending on the debtor. If not treated as a sale, the company grants a security interest in the receivables. The agreement can be terminated with 30 days’ notice or immediately in case of a termination event.
Super Micro Computer, Inc. (NASDAQ:SMCI) develops advanced server and storage systems optimized for global applications in data centers, artificial intelligence, cloud platforms, and edge computing environments.
6. Oracle Corp (NYSE:ORCL)
EPS Growth this Year: 12.49%
Expected 5-Year EPS Growth: 18.04%
Number of Hedge Fund Holders: 97
Oracle Corp (NYSE:ORCL) is one of the growth stocks that could double by 2027. On July 10, Piper Sandler upgraded the stock to ‘Overweight’ and hiked the price target to $270 from $190. The adjustments are in response to significant shifts in CIO spending priorities owing to artificial intelligence.
According to Piper Sandler, a recent CIO Survey has affirmed a significant spending backdrop for AI infrastructure, which heightens risks to the broader application category. Consequently, Oracle remains well-positioned to benefit from the new trend.
“CIOs planning a material increase in OCI spending shot up to 27% from 18%, 15%, and 4% in previous surveys,” the analysts noted. They also cited growing enterprise demand, which could “add another layer of growth to the outsized OpenAI-Stargate opportunity.”
Oracle Corp (NYSE:ORCL) is a technology company that provides a wide range of products and services for enterprise software and cloud computing. It is best known for its database software, particularly the Oracle Database, and also offers a suite of cloud applications for various business functions.
5. Tesla, Inc. (NASDAQ:TSLA)
EPS Growth this Year: -23.91%
Expected 5-Year EPS Growth: 18.19%
Number of Hedge Fund Holders: 104
Tesla, Inc. (NASDAQ:TSLA) is one of the growth stocks that could double by 2027. On July 14, Elon Musk confirmed he is opposed to any merger involving the electric vehicle giant and artificial intelligence company xAI.
The remark came in response to a question posted on the social networking platform X. It comes as the tech billionaire explores the future relationship between the two companies he owns. Musk has already affirmed he is open to a shareholder vote that will determine whether Tesla will invest in the AI company xAI.
Last year, Musk asked his followers on X whether Tesla should proceed with a $5 billion investment in xAI. A majority of the people said yes. Likewise, in March, Musk completed a merger between xAI and X in a deal that valued the AI company at $80 billion and the social network at $33 billion.
Tesla, Inc. (NASDAQ:TSLA) is a tech giant that designs, manufactures, and sells electric vehicles, energy generation and storage products, and related services. It is known for its electric cars, including the Model S, Model 3, Model X, and Model Y, as well as energy products such as the Powerwall and Megapack.
4. Clearwater Analytics Holdings, Inc. (NYSE:CWAN)
EPS Growth this Year: 14.50%
Expected 5-Year EPS Growth: 24.07%
Number of Hedge Fund Holders: 41
Clearwater Analytics Holdings, Inc. (NYSE:CWAN) is one of the growth stocks that could double by 2027. On July 22, McCormick & Company (NYSE:MKC) announced its adoption of Clearwater Analytics’ commercial paper workflow solution to modernize short-term capital raising.
The move comes amid a surge in U.S. commercial paper issuance, which topped $1.4 trillion in May 2025. McCormick’s treasury team cited the need for real-time visibility and cost control in a volatile rate environment.
Clearwater’s platform offers benchmarking tools, maturity tracking, and integrated reconciliation, helping McCormick optimize issuance decisions and dealer performance. The partnership reflects a broader shift among corporations toward tech-enabled liquidity management, especially as short-term rates begin to ease and long-term commitments remain limited.
Clearwater Analytics Holdings, Inc. (NYSE:CWAN) offers cloud-based SaaS solutions for investment data management, serving global financial institutions and government entities. Its core platform, Clearwater Prism, provides tools for reporting, compliance, risk analysis, and reconciliation, while specialized products like LPx, MLx, and JUMP support private funds, mortgage oversight, and full trade lifecycle needs.
3. Assembly Biosciences, Inc. (NASDAQ:ASMB)
EPS Growth this Year: 21.60%
Expected 5-Year EPS Growth: 58.30%
Number of Hedge Fund Holders: 6
Assembly Biosciences, Inc. (NASDAQ:ASMB) is one of the growth stocks that could double by 2027. On June 25, the company announced positive topline results from its Phase 1b trial of ABI-4334, a capsid assembly modulator for the treatment of chronic hepatitis B.
The 28-day study showed HBV DNA reductions of 2.9 log10 IU/mL at 150 mg and 3.2 log10 IU/mL at 400 mg, with additional declines in HBV RNA. The lower dose achieved saturated inhibition of viral replication, while the higher dose may enhance suppression of cccDNA formation, a key viral reservoir.
The drug was well-tolerated, with no serious adverse events and pharmacokinetics supporting once-daily oral dosing. These results activate a licensing decision for Gilead Sciences, which holds rights to further develop ABI-4334.
Assembly Biosciences, Inc. (NASDAQ:ASMB) is a clinical-stage biotech focused on small-molecule therapies for serious viral infections. Its pipeline includes candidates for hepatitis B, hepatitis delta, herpesviruses, and transplant-related infections. The company collaborates with Gilead Sciences to advance next-generation antiviral treatments.
2. Corcept Therapeutics Incorporated (NASDAQ:CORT)
EPS Growth this Year: 11.99%
Expected 5-Year EPS Growth: 69.48%
Number of Hedge Fund Holders: 33
Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the growth stocks that could double by 2027. On July 14, CORT submitted an FDA application for relacorilant to treat platinum-resistant ovarian cancer, based on promising Phase 2 and 3 trial data.
Patients receiving the drug with nab-paclitaxel experienced notable improvements in survival outcomes without added safety risks. With relacorilant already designated as an orphan drug and a decision date set for December 30, 2025, this milestone marks Corcept’s second active NDA submission.
Relacorilant modulates cortisol activity via glucocorticoid receptors and has shown strong clinical potential. Backed by robust financials, including a 128% stock return over the past year and a current ratio of 3.07, Corcept is well-positioned to target the estimated 20,000 U.S. patients needing new therapies for platinum-resistant disease annually. If approved, this drug could significantly enhance treatment options and expand the company’s oncology portfolio.
Corcept Therapeutics Incorporated (NASDAQ:CORT) is a biopharma firm specializing in therapies that regulate cortisol, a key hormone in body function. Its lead product, Korlym, is FDA-approved for treating Cushing’s syndrome, a condition caused by excess cortisol.
1. Circle Internet Group (NYSE:CRCL)
EPS Growth this Year: -61.90%
Expected 5-Year EPS Growth: 78.00%
Number of Hedge Fund Holders: N/A
Circle Internet Group (NYSE:CRCL) is one of the growth stocks that could double by 2027. On July 21, 2025, Circle Internet Group (CRCL) announced the expansion of its Board of Directors from eight to nine members, appointing Adam Selipsky to serve on both its Audit and Strategy Committees. Selipsky, now designated a Class III director, will hold the position until 2028 or until a successor is appointed.
The Board confirmed Selipsky’s independence per NYSE standards, with no related-party disclosures required under SEC regulations. He will receive compensation in line with other non-employee directors serving on the board.
Circle Internet Group (NYSE:CRCL) operates a blockchain-native platform focused on stablecoin infrastructure and services. It issues the widely used U.S. dollar-backed stablecoin and provides enterprise-grade tools for liquidity, payments, tokenized assets, and developer integration across digital finance ecosystems.
While we acknowledge the potential of CRCL to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CRCL and that has 100x upside potential, check out our report about this cheapest AI stock.
READ NEXT: 12 Best Airline Stocks to Buy According to Hedge Funds and Goldman Sachs REIT Stocks: Top 12 Stock Picks.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email below.
